Prosecution Insights
Last updated: November 04, 2026

Denteric Pty Ltd.

Technology area: Biotechnology & Pharmaceuticals

1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready

Analysis

Denteric Pty Ltd. currently has 1 pending office action within the Biotechnology & Pharmaceuticals technology area. This action is assigned to 1 distinct examiner and 1 distinct art unit. CHHAY, BONIRATH is the busiest examiner for this portfolio, with 1 pending office action.

This figure matches the total of 1 pending office action for the entire company, indicating that this examiner is responsible for all current pending prosecution. The focus on 1 distinct art unit suggests that the company's current legal efforts are centralized in one specific area of biotechnology and pharmaceutical review. Because the entire workload is managed by CHHAY, BONIRATH, the prosecution strategy is highly dependent on this single examiner's feedback. This concentration within the Biotechnology & Pharmaceuticals sector highlights a narrow but significant area of interest for the company's current patenting activities. The 1 distinct examiner is responsible for the 1 pending office action currently under review.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

1
Total Pending OAs
1
Non-Final OAs
0
Final Rejections
0
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

1
Hard (100%)
0
Medium (0%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other1 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

1
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

10 h
Manual time on pending OAs
2 h
Time saved (low, 20%)
4 h
Time saved (mid, 35%)
0.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
STEPHENS, AMELIA CAROLE 1 66.7% +44.4%

Hard Cases (1)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18730629 CHIMERIC POLYPEPTIDES STEPHENS, AMELIA CAROLE —

Interview Candidates (1)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18730629 CHIMERIC POLYPEPTIDES STEPHENS, AMELIA CAROLE —

Top Art Units

Art UnitApps
1645 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18730629 CHIMERIC POLYPEPTIDES STEPHENS, AMELIA CAROLE 1645 §101§102§112Other Non-Final OA — Pending Jul 19, 2024

Managing Denteric Pty Ltd.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Denteric Pty Ltd. have?

Denteric Pty Ltd. has 1 pending office actions as of November 2026, spread across 1 art units and 1 examiners.

Which USPTO examiner handles the most Denteric Pty Ltd. applications?

Amelia Carole Stephens has the most, with 1 of Denteric Pty Ltd.'s pending office actions.

What technology area are Denteric Pty Ltd.'s patent applications in?

Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month